Opinion: Pfizer's Dividend Riskier Than It Looks, Even with a 7% Yield
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
We compare high-return candidates for Roth IRA indexing, analyzing volatility, fees, and potential tax-free compounding effects.
28,037 articlesPfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Investors on Wall Street are pouring capital into Ukraine's drone technology, led by Swarmers, signaling a new phase ...
Alibaba shares slid about 7% after quarterly results, underscoring a push into AI and cloud infrastructure. Investors...
A venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...
A Needham note argues that Abercrombie & Fitch could surge as stabilizing sales, strong Hollister growth and aggressi...
Geopolitics can shake travel stocks fast. This article breaks down how Carnival, the world’s largest cruise operator,...
In a crowded AI market, a stock nobody watching that quietly compounds growth could deliver outsized returns. This gu...
SpaceX’s Grok AI platform posted solid revenue yet massive losses in the latest quarter, raising questions about the ...
A retiree outlines a disciplined six-position income plan—three bond ETFs and three high-yield equities—to generate $...
Amid a volatile market and rate shock fears, one investor insists they can't stop buying this tech titan. Apple’s Ser...
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
Microsoft has fallen this year as AI hopes and cloud momentum wobble. Analysts highlight Azure, AI adoption, and cost...